• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

促甲状腺激素分泌不当。

Inappropriate secretion of thyroid-stimulating hormone.

出版信息

Ann Intern Med. 1981 Sep;95(3):339-51. doi: 10.7326/0003-4819-95-3-339.

DOI:10.7326/0003-4819-95-3-339
PMID:7023312
Abstract

Recent studies have provided major new insights into the syndromes of inappropriate secretion of thyroid-stimulating hormone (TSH), a heterogeneous group of disorders in which patients show inappropriately elevated levels of serum immunoactive TSH in the presence of elevated free thyroid hormone levels. Certain of these patients appear to have a non-neoplastic disorder associated with variable degrees of pituitary and peripheral resistance to the action of thyroid hormone, whereas others harbor a tumor of pituitary thyrotropic cells. Measurement of free serum alpha subunit has proved valuable in differentiating these disorders, showing normal alpha concentration and alpha-to-TSH ratios in the non-neoplastic and highly elevated values in the neoplastic disorders. All these syndromes appear unrelated to Graves' disease because thyroid-binding and thyroid-stimulating antibodies are usually absent. Some of these patients also have abnormal metabolism of thyroid hormones. Although the pathogenesis of these syndromes remains to be elucidated, increased recognition and study of these patients should provide fundamental insights into the regulation of TSH secretion as well as the action of thyroid hormone.

摘要

最近的研究对促甲状腺激素(TSH)分泌异常综合征提供了重要的新见解,这是一组异质性疾病,患者在游离甲状腺激素水平升高的情况下血清免疫活性TSH水平却异常升高。其中一些患者似乎患有与不同程度的垂体和外周甲状腺激素作用抵抗相关的非肿瘤性疾病,而另一些患者则患有垂体促甲状腺细胞肿瘤。血清游离α亚基的测定已被证明在区分这些疾病方面很有价值,在非肿瘤性疾病中显示α浓度和α与TSH的比值正常,而在肿瘤性疾病中则显著升高。所有这些综合征似乎都与格雷夫斯病无关,因为通常不存在甲状腺结合抗体和甲状腺刺激抗体。这些患者中的一些人还存在甲状腺激素代谢异常。尽管这些综合征的发病机制仍有待阐明,但对这些患者的更多认识和研究应能为TSH分泌的调节以及甲状腺激素的作用提供基本见解。

相似文献

1
Inappropriate secretion of thyroid-stimulating hormone.促甲状腺激素分泌不当。
Ann Intern Med. 1981 Sep;95(3):339-51. doi: 10.7326/0003-4819-95-3-339.
2
Thyrotropin-producing pituitary adenoma simultaneously existing with Graves' disease: a case report.促甲状腺激素分泌型垂体腺瘤与格雷夫斯病同时存在:一例报告
J Med Case Rep. 2017 Jan 6;11(1):9. doi: 10.1186/s13256-016-1172-4.
3
Thyrotropin-induced hyperthyroidism caused by selective pituitary resistance to thyroid hormone. A new syndrome of "inappropriate secretion of TSH".由选择性垂体对甲状腺激素抵抗引起的促甲状腺素诱导的甲状腺功能亢进症。一种“促甲状腺素分泌不当”的新综合征。
J Clin Invest. 1975 Sep;56(3):633-42. doi: 10.1172/JCI108133.
4
Resistance to thyroid hormones. A disorder frequently confused with Graves' disease.甲状腺激素抵抗。一种常与格雷夫斯病相混淆的病症。
Arch Intern Med. 1982 Oct;142(10):1867-71.
5
Pathogenesis of Hyperthyroidism.甲状腺功能亢进症的发病机制
Compr Physiol. 2016 Dec 6;7(1):67-79. doi: 10.1002/cphy.c160001.
6
Sex hormone-binding globulin measurement in patients with inappropriate secretion of thyrotropin (IST): evidence against selective pituitary thyroid hormone resistance in nonneoplastic IST.促甲状腺激素分泌异常(IST)患者的性激素结合球蛋白测定:非肿瘤性IST中不存在选择性垂体甲状腺激素抵抗的证据
J Clin Endocrinol Metab. 1990 Jul;71(1):19-25. doi: 10.1210/jcem-71-1-19.
7
Thyroid hormone resistance.甲状腺激素抵抗
Postgrad Med J. 2008 Sep;84(995):473-7. doi: 10.1136/pgmj.2008.069740.
8
The spectrum of inappropriate pituitary thyrotropin secretion associated with hyperthyroidism.与甲状腺功能亢进相关的不适当垂体促甲状腺激素分泌谱。
Mayo Clin Proc. 1982 Sep;57(9):556-63.
9
[The syndrome of tissue resistance to thyroid hormones].[甲状腺激素组织抵抗综合征]
Presse Med. 1987 Jun 27;16(25):1234-8.
10
Inappropriate secretion of thyrotropin by the pituitary.垂体促甲状腺激素分泌异常。
Horm Res. 1987;26(1-4):79-99. doi: 10.1159/000180687.

引用本文的文献

1
Graves' disease coexisted with resistance to thyroid hormone: a case report.格雷夫斯病合并甲状腺激素抵抗:一例报告。
J Med Case Rep. 2021 Sep 25;15(1):473. doi: 10.1186/s13256-021-03061-4.
2
An Update on the Pathophysiology and Diagnosis of Inappropriate Secretion of Thyroid-Stimulating Hormone.促甲状腺激素分泌不当的病理生理学和诊断的最新进展。
Int J Mol Sci. 2021 Jun 21;22(12):6611. doi: 10.3390/ijms22126611.
3
Dynamic changes of central thyroid functions in the management of Cushing's syndrome.库欣综合征治疗过程中甲状腺中枢功能的动态变化。
Arch Endocrinol Metab. 2018 Apr 5;62(2):164-171. doi: 10.20945/2359-3997000000019. Print 2018 Mar-Apr.
4
Thyrotropin-producing pituitary adenoma simultaneously existing with Graves' disease: a case report.促甲状腺激素分泌型垂体腺瘤与格雷夫斯病同时存在:一例报告
J Med Case Rep. 2017 Jan 6;11(1):9. doi: 10.1186/s13256-016-1172-4.
5
The syndromes of reduced sensitivity to thyroid hormone.甲状腺激素抵抗综合征
Biochim Biophys Acta. 2013 Jul;1830(7):3987-4003. doi: 10.1016/j.bbagen.2012.08.005. Epub 2012 Aug 16.
6
Hyperactivity and learning deficits in transgenic mice bearing a human mutant thyroid hormone beta1 receptor gene.携带人类突变甲状腺激素β1受体基因的转基因小鼠的多动与学习缺陷
Learn Mem. 1998 Sep-Oct;5(4-5):289-301.
7
A circulating, biologically inactive thyrotropin caused by a mutation in the beta subunit gene.一种由β亚基基因突变导致的循环性、生物活性无活性的促甲状腺激素。
J Clin Invest. 1996 Mar 1;97(5):1250-6. doi: 10.1172/JCI118540.
8
Identical mutations in unrelated families with generalized resistance to thyroid hormone occur in cytosine-guanine-rich areas of the thyroid hormone receptor beta gene. Analysis of 15 families.在对15个家庭的分析中发现,甲状腺激素受体β基因富含胞嘧啶-鸟嘌呤的区域出现了与甲状腺激素普遍抵抗相关的不相关家庭中的相同突变。
J Clin Invest. 1993 Jun;91(6):2408-15. doi: 10.1172/JCI116474.
9
Hyperthyroidism due to a thyrotropin secreting pituitary adenoma.促甲状腺素分泌型垂体腺瘤所致甲状腺功能亢进症。
Ir J Med Sci. 1985 Sep;154(9):358-60. doi: 10.1007/BF02937182.
10
Glycoprotein hormone genes are expressed in clinically nonfunctioning pituitary adenomas.糖蛋白激素基因在临床上无功能的垂体腺瘤中表达。
J Clin Invest. 1987 Nov;80(5):1472-8. doi: 10.1172/JCI113228.